Calyx spins off medical imaging, eClinical solutions firm
Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.
Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.
The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.
The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic.